Catheter Precision (VTAK) welcomed Marie-Claude Jacques as Chief Commercial Officer. Marie-Claude will be responsible for the commercialization team including sales and marketing to develop new business opportunities and improve the customer experience. Before joining Catheter Precision Inc, Mrs. Jacques worked as Area Vice President, Commercialization & Strategy at Boston Scientific Corporation (BSX).
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VTAK:
- Catheter Precision receives first purchase order for LockeT from HCA Healthcare
- Catheter Precision price target lowered to $4.10 from $7 at Ladenburg
- Catheter Precision expects cash flow break even by end of calendar year
- Catheter Precision expands sales team
- Catheter Precision Q4 revenue $128,800 vs. $0 last year
